Results 221 to 230 of about 48,688 (308)

VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms

open access: yesNeuropsychopharmacology, 2006
C. Nemeroff   +8 more
semanticscholar   +1 more source

Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation. [PDF]

open access: yesCardiovasc Res
Jani NR   +12 more
europepmc   +1 more source

Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report. [PDF]

open access: yesInt J Neuropsychopharmacol
Conway CR   +31 more
europepmc   +1 more source

Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome

open access: yesNeuropsychopharmacology, 2001
H. Sackeim   +11 more
semanticscholar   +1 more source

Virtual Nursing for the Care of Hospitalized Patients.

open access: yesJAMA Netw Open
Muir KJ   +5 more
europepmc   +1 more source

Driving after vagus nerve stimulation therapy: Is it possible? [PDF]

open access: yesEpilepsia Open
Peña-Ceballos J   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy